Borderline Personality Disorder
Borderline Personality Disorder
comorbidities such as substance misuse disorder, major depressive d
The essential feature here with these patients is distrust and being suspicious of others and their surroundings, therefore in order to be able to have any kind of therapeutic or therapist relationship with them one has to first get their trust completely. Make them feel that you are completely on their side by sharing with them that you respect what they believe but you don’t share it or have the same belief, that you have nothing that can harm them, that you are genuine and are there only for them (Carroll, 2018). Once that is established, which may take some time and patience on the therapist part, then little by little we can point various things out to them to help them see that what they perceived as evil is not it and from these little examples that are clarified then we can explain to them the disorder or problem they have.
Colleagues Respond# 2
Different types of personality disorders disturb an individual and thus affect the way they think, behave, reason, and act but in this week’s discussion Post, I chose to discuss Borderline Personality Disorder (BPD).
Borderline Personality Disorder
BPD is a severe personality disorder categorized by impulsivity, affective instability, relationship problems, and identity problems. It affects 1-2% of the overall population, 10% of the patients in outpatient settings, 15-20% of the patients in inpatients settings, and 30-60% of the patients diagnosed with personality disorders. This uncertainty often disrupts family and work life, long-term planning, and the individual’s sense of self-identity. Originally thought to be at the borderline of psychosis, people with BPD suffer from a disorder of emotion regulation. BPD is very normally considered according to the diagnostic and statistical manual of mental disorders. Additionally, evaluation of BPD geographies on a measurable or dimensional scale is gradually used (Jackson, & Westbrook, 2009). This disorder is frequently detected in women in clinical sections and young individuals and is often co-morbid with other personality and axis-I disorders. Researchers using ecological temporary calculation strongly indicates that these individuals react in abnormal ways to interpersonal convict (Fitzpatrick, Maich, Carney, & Kuo, 2020). Recently, neurobiological studies showed that symptoms and behaviors of BPD are partly associated with alterations in basic neurocognitive processes, involving glutamatergic, dopaminergic, and serotoninergic systems. Additionally, neuroimaging studies in BPD patients indicated differences in the volume and activity of specific brain regions related to emotion and impulsivity, such as the prefrontal cortex, cingulate cortex, amygdala, and hippocampus. According to the DSM-IV-R, an individual must have at least 5 out of 9 of the following symptoms present for an accurate diagnosis to be made. These are extreme efforts to avoid real or imagined abandonment, unstable and intense interpersonal relationships, identity disturbance, potentially self-damaging impulsivity, affective instability due to a marked reactivity of mood, chronic feelings of emptiness, and inappropriate intense anger or lack of control of anger (Jackson, & Westbrook, 2009).
Therapeutic Approach
There has not been any specific drug approved by the FDA to treat BPD, although some have broad product licenses that cover individual symptoms or symptom clusters. Where there is a diagnosis of
isorder, agoraphobia and OCD
